Search

Jen-Kuei Liu

from Palo Alto, CA

Jen-Kuei Liu Phones & Addresses

  • Palo Alto, CA

Work

  • Company:
    Life technologies

Education

  • School / High School:
    Brown University- Providence, RI
  • Specialities:
    Ph.D. in Biochemistry

Resumes

Jen-Kuei Liu Photo 1

Jen-Kuei Liu Palo Alto, CA

view source
Work:
Life Technologies

2008 to 2000
R&D of

2011 to 2012
Developed QC
Applied Biosystems
Foster City, CA
2007 to 2008
Senior Staff Scientist
Applied Biosystems
Foster City, CA
2005 to 2007
Senior Staff Scientist, Fluidics and Device Systems
AGY Therapeutics, Inc
South San Francisco, CA
2001 to 2005
Director of Molecular Biology and Protein Biochemistry
Molecular Biology Group

2000 to 2001
Group Leader of Molecular Biology
Roche Diagnostic Corporation
Berkeley, CA
1999 to 2000
Project Leader
Sentinel Biosciences, Inc
Palo Alto, CA
1997 to 1999
Project Manager, Hepatitis Virus Discovery
SVI and SVII

1996 to 1997
Senior Scientist, Virus Discovery and Technology Development
Langley Porter Psychiatric Institute
San Francisco, CA
1992 to 1996
Early development
Education:
Brown University
Providence, RI
Ph.D. in Biochemistry
National Taiwan University
B.Sc. in Biology

Us Patents

  • Sentinel Virus Ii

    view source
  • US Patent:
    20030165540, Sep 4, 2003
  • Filed:
    May 4, 2001
  • Appl. No.:
    09/849729
  • Inventors:
    Jen-Kuei Liu - Palo Alto CA, US
    Samantha Lewis - San Francisco CA, US
    Hans-Georg Batz - Tutzing, DE
    Latha Ramaswamy - San Jose CA, US
    Roy Bohenzky - Mountain View CA, US
    Yu-Huei Lin - Sunnyvale CA, US
    Janine Montiel - Fremont CA, US
    Benjamin Chen - Fremont CA, US
  • International Classification:
    A61K039/29
    C12Q001/70
    C07H021/04
    C12N007/00
  • US Classification:
    424/225100, 435/005000, 536/023720, 435/235100
  • Abstract:
    The invention relates to a new virus, designated H101.c33 or Sentinel Virus II (SVII). Isolated SVII viruses, polynucleotides and proteins from SVII viruses, and antibodies which bind SVII virus and SVII viral proteins are provided. The polynucleotides, proteins, and antibodies of the invention may be used to detect SVII virus or infection by SVII virus in a susceptible individual. Additionally, polynucleotides of the invention may be inserted into recombinant expression vectors for recombinant production of viral proteins.
  • Hepatitis Virus Sentinel Virus I (Svi)

    view source
  • US Patent:
    20030198947, Oct 23, 2003
  • Filed:
    Jun 3, 2003
  • Appl. No.:
    10/453264
  • Inventors:
    Jen-Kuei Liu - Palo Alto CA, US
    Roy Bohenzky - Mountain View CA, US
    Yu-Huei Lin - Sunnyvale CA, US
    Benjamin Chen - Fremont CA, US
  • International Classification:
    C12Q001/70
    G01N033/53
    C07H021/02
    C12N007/00
    C12N015/00
    C12N015/70
    C12N005/16
    C07K001/00
    C07K014/00
    C07K017/00
    C12Q001/68
    A61K039/29
    C12N007/02
  • US Classification:
    435/005000, 424/189100, 435/235100, 435/239000, 435/320100, 435/326000, 435/339000, 435/006000, 435/007100, 530/350000, 536/023100, 536/023720
  • Abstract:
    The invention relates to a new group of viruses, designated SVI. Isolated SVI viruses, polynucleotides and proteins from SVI viruses, and antibodies which bind SVI virus and SVI viral proteins are provided. The polynucleotides, proteins, and antibodies of the invention may be used to detect SVI virus or infection by SVI virus in a susceptible individual. Additionally, polynucleotides of the invention may be inserted into recombinant expression vectors recombinant production of viral proteins.
  • Discriminatory Positive/Extraction Control Dna

    view source
  • US Patent:
    20100273143, Oct 28, 2010
  • Filed:
    Mar 25, 2010
  • Appl. No.:
    12/731806
  • Inventors:
    Michael Brewer - Boulder CO, US
    Jen-Kuei Liu - Palo Alto CA, US
    Craig Cummings - Pacifica CA, US
  • Assignee:
    LIFE TECHNOLOGIES CORPORATION - Carlsbad CA
  • International Classification:
    C12Q 1/70
    C07H 21/04
    C12Q 1/68
  • US Classification:
    435 5, 536 237, 435 6
  • Abstract:
    The present teachings generally relate to methods and kits incorporating a discriminating positive control for determining whether a particular microorganism or group of microorganisms are present in a sample, for example but not limited to a food, environmental, agricultural, biopharmaceutical, pharmaceutical, or water sample. According to certain methods, at least part of a starting material, for example but not limited to, a food, environmental, agricultural, biopharmaceutical, pharmaceutical, or water sample can be combined with a culture medium and incubated under conditions suitable for microbial growth followed by extracting microorganism and added control nucleic acids for analysis. The extracted nucleic acids are amplified and the amplified nucleic acids are detected, directly or indirectly, and the fidelity of the methods and the presence or absence of the corresponding microorganism is determined because the discriminating positive control provides both confirmatory results for the methods used but eliminates false positive results.
  • Multi-Primer Assay For Mycoplasma Detection

    view source
  • US Patent:
    20110111403, May 12, 2011
  • Filed:
    Oct 29, 2010
  • Appl. No.:
    12/916420
  • Inventors:
    Pius Brzoska - Woodside CA, US
    Somaya Bit - San Ramon CA, US
    Jen-Kuei Liu - Palo Alto CA, US
    Robert Tebbs - Livermore CA, US
    Manohar Furtado - San Ramon CA, US
  • Assignee:
    LIFE TECHNOLOGIES CORPORATION - Carlsbad CA
  • International Classification:
    C12Q 1/68
    C07H 21/04
  • US Classification:
    435 6, 536 2433
  • Abstract:
    Disclosed is a multi-primer amplification assay, method and kits for detecting species and closely related species utilizing a plurality of oligonucleotide primers in contact with a sample in a single vessel and detecting the amplification product, wherein the presence of an amplification product indicates in the sample.
  • Hepatitis Virus Sentinel Virus I (Svi)

    view source
  • US Patent:
    20010034018, Oct 25, 2001
  • Filed:
    Dec 8, 2000
  • Appl. No.:
    09/732665
  • Inventors:
    Jen-Kuei Liu - Palo Alto CA, US
    Roy Bohenzky - Mountain View CA, US
    Yu-Huei Lin - Sunnyvale CA, US
    Benjamin Chen - Fremont CA, US
  • International Classification:
    C12Q001/70
    C07H021/04
    A61K039/29
    C12N007/00
    G01N033/53
    C07K001/00
  • US Classification:
    435/005000, 536/023720, 424/189100, 435/006000, 435/007100, 435/235100, 435/239000, 435/326000, 435/339000, 435/320100, 530/350000, 536/023100
  • Abstract:
    The invention relates to a new group of viruses, designated SVI. Isolated SVI viruses, polynucleotides and proteins from SVI viruses, and antibodies which bind SVI virus and SVI viral proteins are provided. The polynucleotides, proteins, and antibodies of the invention may be used to detect SVI virus or infection by SVI virus in a susceptible individual. Additionally, polynucleotides of the invention may be inserted into recombinant expression vectors recombinant production of viral proteins.
  • Multi-Primer Assay For Mycoplasma Detection

    view source
  • US Patent:
    20140378330, Dec 25, 2014
  • Filed:
    Jun 25, 2014
  • Appl. No.:
    14/314985
  • Inventors:
    - Carlsbad CA, US
    Pius Brzoska - Woodside CA, US
    Somaya Bit - San Ramon CA, US
    Jen-Kuei Liu - Palo Alto CA, US
    Robert Tebbs - Austin TX, US
    Manohar Furtado - San Ramon CA, US
  • International Classification:
    C12Q 1/68
  • US Classification:
    506 9, 506 23, 506 16
  • Abstract:
    Disclosed is a multi-primer amplification assay, method and kits for detecting species and closely related species utilizing a plurality of oligonucleotide primers in contact with a sample in a single vessel and detecting the amplification product, wherein the presence of an amplification product indicates in the sample.

Get Report for Jen-Kuei Liu from Palo Alto, CA
Control profile